| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | 0.3 | 1.2 | 3.8 | 1062.5 | 528.8 | 7.2 | - | - | 1603.8 |
| 1 | - | - | 0.1 | 0.2 | 0.7 | 216.7 | 101.4 | 0.2 | - | - | 319.3 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | - |
| 1 | - |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | - |
| 1 | - |
| Number of post synapses: | 20850 |
| Number of pre synapses: | 4151 |
| Number of output connections: | 19535 |
| Coverage factor: | 2.4 |
| Columnar completeness: | 0.95 |
| Area completeness: | 0.97 |
| Cell size (columns): | 133 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#Cm21 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi15 (R) | ACh | 6,524 | 501.8 | 31.7% | 31.7% |
| 1 | MeTu3c (R) | ACh | 3,853 | 296.4 | 18.7% | 50.4% |
| 2 | MeTu3a (R) | ACh | 1,417 | 109.0 | 6.9% | 57.3% |
| 3 | aMe17e (R) | Glu | 1,220 | 93.8 | 5.9% | 63.2% |
| 4 | MeTu1 (R) | ACh | 1,085 | 83.5 | 5.3% | 68.5% |
| 5 | MeTu3b (R) | ACh | 1,033 | 79.5 | 5.0% | 73.5% |
| 6 | aMe9 (R) | ACh | 399 | 30.7 | 1.9% | 75.4% |
| 7 | MeVC20 (R) | Glu | 399 | 30.7 | 1.9% | 77.4% |
| 8 | TmY10 (R) | ACh | 376 | 28.9 | 1.8% | 79.2% |
| 9 | MeVP7 (R) | ACh | 274 | 21.1 | 1.3% | 80.5% |
| 10 | Tm5a (R) | ACh | 255 | 19.6 | 1.2% | 81.8% |
| 11 | Cm22 (R) | GABA | 239 | 18.4 | 1.2% | 82.9% |
| 12 | Cm6 (R) | GABA | 238 | 18.3 | 1.2% | 84.1% |
| 13 | Dm2 (R) | ACh | 227 | 17.5 | 1.1% | 85.2% |
| 14 | Cm8 (R) | GABA | 201 | 15.5 | 1.0% | 86.1% |
| 15 | MeVPMe10 (L) | Glu | 176 | 13.5 | 0.9% | 87.0% |
| 16 | Cm28 (R) | unclear | 143 | 11.0 | 0.7% | 87.7% |
| 17 | Cm18 (R) | Glu | 136 | 10.5 | 0.7% | 88.4% |
| 18 | Tm39 (R) | ACh | 128 | 9.8 | 0.6% | 89.0% |
| 19 | Cm7 (R) | Glu | 119 | 9.2 | 0.6% | 89.6% |
| 20 | Cm24 (R) | Glu | 112 | 8.6 | 0.5% | 90.1% |
| 21 | aMe17a (R) | Glu | 103 | 7.9 | 0.5% | 90.6% |
| 22 | Cm3 (R) | GABA | 102 | 7.8 | 0.5% | 91.1% |
| 23 | Cm31a (R) | GABA | 98 | 7.5 | 0.5% | 91.6% |
| 24 | MeVP15 (R) | ACh | 97 | 7.5 | 0.5% | 92.0% |
| 25 | Cm4 (R) | Glu | 90 | 6.9 | 0.4% | 92.5% |
| 26 | Cm34 (R) | Glu | 79 | 6.1 | 0.4% | 92.9% |
| 27 | Dm-DRA1 (R) | Glu | 73 | 5.6 | 0.4% | 93.2% |
| 28 | Mi10 (R) | ACh | 62 | 4.8 | 0.3% | 93.5% |
| 29 | aMe5 (R) | ACh | 57 | 4.4 | 0.3% | 93.8% |
| 30 | aMe10 (R) | ACh | 54 | 4.2 | 0.3% | 94.1% |
| 31 | MeTu2a (R) | ACh | 54 | 4.2 | 0.3% | 94.3% |
| 32 | Cm16 (R) | Glu | 45 | 3.5 | 0.2% | 94.5% |
| 33 | TmY5a (R) | Glu | 39 | 3.0 | 0.2% | 94.7% |
| 34 | MeVP31 (R) | ACh | 38 | 2.9 | 0.2% | 94.9% |
| 35 | Cm20 (R) | GABA | 37 | 2.8 | 0.2% | 95.1% |
| 36 | MeVP12 (R) | ACh | 37 | 2.8 | 0.2% | 95.3% |
| 37 | Tm29 (R) | Glu | 35 | 2.7 | 0.2% | 95.4% |
| 38 | Cm14 (R) | GABA | 32 | 2.5 | 0.2% | 95.6% |
| 39 | MeVC22 (R) | Glu | 32 | 2.5 | 0.2% | 95.8% |
| 40 | Tm5c (R) | Glu | 32 | 2.5 | 0.2% | 95.9% |
| 41 | TmY17 (R) | ACh | 32 | 2.5 | 0.2% | 96.1% |
| 42 | OA-AL2i4 (R) | OA | 29 | 2.2 | 0.1% | 96.2% |
| 43 | MeVP14 (R) | ACh | 28 | 2.2 | 0.1% | 96.3% |
| 44 | Cm-DRA (R) | ACh | 27 | 2.1 | 0.1% | 96.5% |
| 45 | MeVP2 (R) | ACh | 25 | 1.9 | 0.1% | 96.6% |
| 46 | Cm31b (R) | GABA | 24 | 1.8 | 0.1% | 96.7% |
| 47 | MeLo4 (R) | ACh | 23 | 1.8 | 0.1% | 96.8% |
| 48 | MeVP6 (R) | Glu | 23 | 1.8 | 0.1% | 96.9% |
| 49 | Mi9 (R) | Glu | 23 | 1.8 | 0.1% | 97.0% |
| 50 | R7d (R) | His | 21 | 1.6 | 0.1% | 97.1% |
| 51 | R7y (R) | His | 21 | 1.6 | 0.1% | 97.2% |
| 52 | Tm32 (R) | Glu | 19 | 1.5 | 0.1% | 97.3% |
| 53 | MeVC2 (L) | ACh | 18 | 1.4 | 0.1% | 97.4% |
| 54 | Cm21 (R) | GABA | 17 | 1.3 | 0.1% | 97.5% |
| 55 | LT58 (R) | Glu | 17 | 1.3 | 0.1% | 97.6% |
| 56 | MeVC6 (L) | ACh | 17 | 1.3 | 0.1% | 97.7% |
| 57 | MeVC_unclear (R) | Glu | 17 | 1.3 | 0.1% | 97.8% |
| 58 | MeVPMe12 (R) | ACh | 17 | 1.3 | 0.1% | 97.8% |
| 59 | R7_unclear (R) | His | 16 | 1.2 | 0.1% | 97.9% |
| 60 | Cm17 (R) | GABA | 15 | 1.2 | 0.1% | 98.0% |
| 61 | Cm5 (R) | GABA | 15 | 1.2 | 0.1% | 98.1% |
| 62 | Pm12 (R) | Glu | 15 | 1.2 | 0.1% | 98.1% |
| 63 | TmY13 (R) | ACh | 15 | 1.2 | 0.1% | 98.2% |
| 64 | Cm9 (R) | Glu | 14 | 1.1 | 0.1% | 98.3% |
| instance | NT | total connections | connections /#Cm21 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi15 (R) | ACh | 9,318 | 716.8 | 47.7% | 47.7% |
| 1 | Cm5 (R) | GABA | 1,182 | 90.9 | 6.1% | 53.8% |
| 2 | Tm37 (R) | Glu | 908 | 69.8 | 4.6% | 58.4% |
| 3 | Cm20 (R) | GABA | 814 | 62.6 | 4.2% | 62.6% |
| 4 | Cm4 (R) | Glu | 688 | 52.9 | 3.5% | 66.1% |
| 5 | MeTu3c (R) | ACh | 589 | 45.3 | 3.0% | 69.1% |
| 6 | MeTu3b (R) | ACh | 364 | 28.0 | 1.9% | 71.0% |
| 7 | Dm2 (R) | ACh | 336 | 25.8 | 1.7% | 72.7% |
| 8 | Cm14 (R) | GABA | 321 | 24.7 | 1.6% | 74.3% |
| 9 | Tm39 (R) | ACh | 282 | 21.7 | 1.4% | 75.8% |
| 10 | Mi10 (R) | ACh | 270 | 20.8 | 1.4% | 77.2% |
| 11 | T2 (R) | ACh | 269 | 20.7 | 1.4% | 78.5% |
| 12 | Cm18 (R) | Glu | 255 | 19.6 | 1.3% | 79.8% |
| 13 | Cm13 (R) | Glu | 225 | 17.3 | 1.2% | 81.0% |
| 14 | Cm6 (R) | GABA | 163 | 12.5 | 0.8% | 81.8% |
| 15 | MeTu1 (R) | ACh | 155 | 11.9 | 0.8% | 82.6% |
| 16 | MeVP59 (R) | ACh | 151 | 11.6 | 0.8% | 83.4% |
| 17 | Cm7 (R) | Glu | 150 | 11.5 | 0.8% | 84.2% |
| 18 | Tm5c (R) | Glu | 126 | 9.7 | 0.6% | 84.8% |
| 19 | MeVP7 (R) | ACh | 107 | 8.2 | 0.5% | 85.4% |
| 20 | MeTu3a (R) | ACh | 105 | 8.1 | 0.5% | 85.9% |
| 21 | TmY18 (R) | ACh | 103 | 7.9 | 0.5% | 86.4% |
| 22 | MeVPMe10 (R) | Glu | 95 | 7.3 | 0.5% | 86.9% |
| 23 | Cm9 (R) | Glu | 94 | 7.2 | 0.5% | 87.4% |
| 24 | Cm8 (R) | GABA | 72 | 5.5 | 0.4% | 87.8% |
| 25 | Tm36 (R) | ACh | 71 | 5.5 | 0.4% | 88.1% |
| 26 | MeVPLo1 (R) | Glu | 70 | 5.4 | 0.4% | 88.5% |
| 27 | Cm10 (R) | GABA | 64 | 4.9 | 0.3% | 88.8% |
| 28 | Mi16 (R) | GABA | 64 | 4.9 | 0.3% | 89.1% |
| 29 | Tm31 (R) | Glu | 61 | 4.7 | 0.3% | 89.5% |
| 30 | MeVP33 (R) | ACh | 56 | 4.3 | 0.3% | 89.7% |
| 31 | MeVP9 (R) | ACh | 55 | 4.2 | 0.3% | 90.0% |
| 32 | Cm12 (R) | GABA | 52 | 4.0 | 0.3% | 90.3% |
| 33 | MeTu2b (R) | unclear | 51 | 3.9 | 0.3% | 90.5% |
| 34 | aMe9 (R) | ACh | 50 | 3.8 | 0.3% | 90.8% |
| 35 | MeVPMe12 (R) | ACh | 50 | 3.8 | 0.3% | 91.1% |
| 36 | MeVP8 (R) | ACh | 49 | 3.8 | 0.3% | 91.3% |
| 37 | Dm20 (R) | Glu | 46 | 3.5 | 0.2% | 91.5% |
| 38 | MeVP52 (R) | ACh | 42 | 3.2 | 0.2% | 91.8% |
| 39 | Cm3 (R) | GABA | 39 | 3.0 | 0.2% | 92.0% |
| 40 | Dm-DRA1 (R) | Glu | 38 | 2.9 | 0.2% | 92.2% |
| 41 | MeVP12 (R) | ACh | 37 | 2.8 | 0.2% | 92.3% |
| 42 | MeVP32 (R) | ACh | 35 | 2.7 | 0.2% | 92.5% |
| 43 | Mi18 (R) | GABA | 34 | 2.6 | 0.2% | 92.7% |
| 44 | MeVP1 (R) | ACh | 32 | 2.5 | 0.2% | 92.9% |
| 45 | MeVC24 (R) | Glu | 31 | 2.4 | 0.2% | 93.0% |
| 46 | aMe17c (R) | Glu | 30 | 2.3 | 0.2% | 93.2% |
| 47 | Cm11d (R) | ACh | 28 | 2.2 | 0.1% | 93.3% |
| 48 | Cm26 (R) | Glu | 28 | 2.2 | 0.1% | 93.5% |
| 49 | Cm22 (R) | GABA | 27 | 2.1 | 0.1% | 93.6% |
| 50 | TmY5a (R) | Glu | 27 | 2.1 | 0.1% | 93.7% |
| 51 | Tm9 (R) | ACh | 25 | 1.9 | 0.1% | 93.9% |
| 52 | Cm30 (R) | GABA | 24 | 1.8 | 0.1% | 94.0% |
| 53 | MeTu2a (R) | ACh | 24 | 1.8 | 0.1% | 94.1% |
| 54 | MeVP6 (R) | Glu | 24 | 1.8 | 0.1% | 94.2% |
| 55 | aMe2 (R) | Glu | 23 | 1.8 | 0.1% | 94.4% |
| 56 | Tm16 (R) | ACh | 23 | 1.8 | 0.1% | 94.5% |
| 57 | Tm34 (R) | Glu | 23 | 1.8 | 0.1% | 94.6% |
| 58 | LT58 (R) | Glu | 22 | 1.7 | 0.1% | 94.7% |
| 59 | Cm11a (R) | ACh | 21 | 1.6 | 0.1% | 94.8% |
| 60 | MeLo6 (R) | ACh | 21 | 1.6 | 0.1% | 94.9% |
| 61 | MeVP57 (R) | unclear | 21 | 1.6 | 0.1% | 95.0% |
| 62 | MeVP41 (R) | ACh | 20 | 1.5 | 0.1% | 95.1% |
| 63 | aMe5 (R) | ACh | 19 | 1.5 | 0.1% | 95.2% |
| 64 | MeTu4d (R) | ACh | 19 | 1.5 | 0.1% | 95.3% |
| 65 | Cm35 (R) | GABA | 18 | 1.4 | 0.1% | 95.4% |
| 66 | MeVP21 (R) | ACh | 18 | 1.4 | 0.1% | 95.5% |
| 67 | MeVPMe11 (R) | Glu | 18 | 1.4 | 0.1% | 95.6% |
| 68 | TmY15 (R) | GABA | 18 | 1.4 | 0.1% | 95.7% |
| 69 | Cm21 (R) | GABA | 17 | 1.3 | 0.1% | 95.8% |
| 70 | Cm28 (R) | unclear | 16 | 1.2 | 0.1% | 95.9% |
| 71 | Cm31b (R) | GABA | 15 | 1.2 | 0.1% | 95.9% |
| 72 | Mi1 (R) | ACh | 15 | 1.2 | 0.1% | 96.0% |
| 73 | TmY10 (R) | ACh | 15 | 1.2 | 0.1% | 96.1% |
| 74 | Cm23 (R) | Glu | 14 | 1.1 | 0.1% | 96.2% |
| 75 | OA-AL2i4 (R) | OA | 14 | 1.1 | 0.1% | 96.2% |
| 76 | Tm_unclear (R) | GABA | 14 | 1.1 | 0.1% | 96.3% |
| 77 | Cm16 (R) | Glu | 13 | 1.0 | 0.1% | 96.4% |
| 78 | L1 (R) | Glu | 13 | 1.0 | 0.1% | 96.4% |
| 79 | MeLo3a (R) | ACh | 13 | 1.0 | 0.1% | 96.5% |
| 80 | MeVC20 (R) | Glu | 13 | 1.0 | 0.1% | 96.6% |
| 81 | MeVP22 (R) | GABA | 13 | 1.0 | 0.1% | 96.6% |
| 82 | Tm33 (R) | ACh | 13 | 1.0 | 0.1% | 96.7% |
| 83 | Tm38 (R) | ACh | 13 | 1.0 | 0.1% | 96.8% |
| 84 | Tm5Y (R) | ACh | 13 | 1.0 | 0.1% | 96.8% |